Target intelligence / Profile preview

Adipocyte metabolism

Molecular classification
Other (not a single molecule, receptor, enzyme, transporter, or gene product; refers to the collective metabolic processes within adipocytes)
01

Overview

“Adipocyte metabolism” does not refer to a single molecule, protein, receptor, enzyme, transporter, or gene product. Instead, it encompasses the collective biochemical processes occurring within fat cells—primarily white and brown adipocytes—including energy storage as triglycerides during times of nutrient excess and mobilization through lipolysis when energy is needed by peripheral tissues. These processes are tightly regulated by hormonal signals such as insulin (which promotes lipid storage) and catecholamines like norepinephrine/adrenaline acting on β-adrenoceptors (which stimulate lipolysis). In addition to their role in energy balance, adipocytes secrete numerous bioactive molecules known as adipokines—including leptin and adiponectin—that regulate appetite control, inflammation status, insulin sensitivity throughout the body,[1][2]and overall metabolic health.[4] Dysfunctional regulation leads to diseases like obesity-related insulin resistance.[5] Because “adipocyte metabolism” describes an entire set of cellular functions rather than an individual druggable entity or therapeutic target classically defined in pharmacology/biomedicine,[7] it should not be considered a canonical molecular target.

Other names
Fat cell metabolismLipid metabolism in adipocytesAdipose tissue metabolic function
02

Mechanism of action

Not applicable to "adipocyte metabolism" itself. Mechanisms depend on the specific molecular targets within this process: - Stimulation/inhibition of lipolysis via hormone-sensitive pathways - Modulation of insulin sensitivity through PPARγ activation or mTORC2 signaling - Regulation of thermogenesis via UCP1 in brown adipocytes

03

Biological functions

Energy storage and releaseLipolysis and lipogenesisEndocrine signaling (adipokine secretion)Regulation of systemic glucose and lipid homeostasis
04

Disease associations

ObesityType 2 diabetes mellitusInsulin resistance/metabolic syndromeCardiovascular disease (indirectly via systemic effects)
05

Interacting drugs

β-Adrenergic agonists/antagonists (e.g., isoproterenol)

3 more in the full profile.

Beyond the preview

Go deeper on Adipocyte metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipocyte metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call